Change

In € millions

 

20031

 

2004

 

20052

 

2006

 

2007

 

20083

 

2009

 

2010

 

20115

 

2012

1

The 2003 figures have not been restated to IFRS accounting standards.

2

The 2003–2005 figures have not been restated for the Organon BioSciences divestment.

3

Continuing operations from ICI are included as from 2008. The 2008 figures have not been restated for the National Starch divestment.

4

Not meaningful as income was a loss.

5

Restated to present Decorative Paints North America as a discontinued operation.

Revenue

 

13,106

 

12,833

 

13,000

 

10,023

 

10,217

 

15,415

 

13,028

 

14,640

 

14,604

 

15,390

Operating income

 

1,146

 

1,588

 

1,492

 

887

 

778

 

(577)

 

855

 

1,219

 

1,145

 

(1,244)

Financing income and expenses

 

(248)

 

(205)

 

(162)

 

(134)

 

(151)

 

(232)

 

(405)

 

(327)

 

(336)

 

(267)

Income tax

 

(254)

 

(412)

 

(338)

 

(96)

 

(166)

 

(260)

 

(141)

 

(170)

 

(233)

 

(172)

Results from associates and joint ventures

 

7

 

10

 

6

 

87

 

(20)

 

25

 

21

 

25

 

24

 

13

Profit for the period from continuing operations

 

651

 

981

 

998

 

744

 

441

 

(1,044)

 

330

 

747

 

600

 

(1,670)

Minority interests attributable to minority shareholders

 

(49)

 

(36)

 

(37)

 

(29)

 

(31)

 

(65)

 

(77)

 

(83)

 

(64)

 

(63)

Discontinued operations

 

 

 

 

438

 

9

 

23

 

32

 

90

 

(59)

 

(436)

Net income, attributable to shareholders

 

602

 

945

 

961

 

1,153

 

419

 

(1,086)

 

285

 

754

 

477

 

(2,169)

Common shares, in millions
at year-end

 

285.7

 

285.8

 

285.8

 

287.0

 

262.3

 

231.7

 

232.3

 

233.5

 

234.7

 

239.0

Dividend

 

343

 

343

 

343

 

344

 

472

 

417

 

325

 

320

 

304

 

214

Number of employees
at year-end

 

64,600

 

61,400

 

61,300

 

42,700

 

42,600

 

60,000

 

54,700

 

55,600

 

52,020

 

50,610

Average number of employees

 

66,400

 

63,600

 

61,400

 

61,900

 

42,600

 

61,300

 

56,300

 

55,100

 

51,100

 

52,200

Employee benefits

 

3,505

 

3,216

 

3,221

 

2,158

 

2,215

 

3,022

 

2,955

 

2,980

 

2,765

 

3,129

Average revenue per employee (in €1,000)

 

197

 

202

 

212

 

162

 

240

 

252

 

231

 

266

 

286

 

295

Average EBITDA per employee (in €1,000)

 

30

 

28

 

34

 

30

 

30

 

31

 

31

 

36

 

36

 

36

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ratios

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income in % of revenue

 

8.7

 

12.4

 

11.5

 

8.8

 

7.6

 

4

 

6.6

 

8.3

 

7.8

 

4

Operating income in % of invested capital

 

13.6

 

20.8

 

19.4

 

16.3

 

14.6

 

4

 

7.3

 

9.6

 

9.1

 

4

Net income in % of shareholders’ equity

 

26.2

 

40.6

 

32.0

 

30.5

 

122.9

 

4

 

3.7

 

8.4

 

5.2

 

4

Employee benefits in % of revenue

 

26.7

 

25.1

 

24.8

 

21.5

 

21.7

 

19.6

 

22.7

 

20.4

 

19.3

 

20.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Per share information (in €)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

2.11

 

3.31

 

3.36

 

4.02

 

33.82

 

(4.38)

 

1.23

 

3.23

 

2.04

 

(9.14)

Adjusted earnings

 

 

 

 

 

 

 

 

 

 

 

 

 

2.06

 

3.71

 

3.10

 

3.26

Shareholders’ equity

 

8.76

 

9.12

 

11.95

 

14.44

 

42.06

 

32.21

 

33.47

 

38.48

 

39.25

 

28.84

Highest share price during the year

 

32.44

 

33.79

 

40.18

 

49.41

 

65.56

 

57.11

 

46.52

 

47.70

 

53.74

 

49.98

Lowest share price during the year

 

16.00

 

24.87

 

30.82

 

38.30

 

44.41

 

22.85

 

26.01

 

37.18

 

29.25

 

34.85

Year-end share price

 

30.60

 

31.38

 

39.15

 

46.18

 

54.79

 

29.44

 

46.40

 

46.49

 

37.36

 

49.75

Case studies

Part of our contribution
to the world around us

Show case study overview

Interactive key figures

Select and compare key data,
create your own charts

Key figures comparison
Keyword Search
Copyright © 2013 Akzo Nobel N.V.